Move as one with the first FDA cleared exoskeleton indicated for stroke and spinal cord injury rehabilitation that is designed to help patients get back on their feet supporting re-learning of correct step patterns, weight shifting, and potentially mitigating compensatory behaviors.
At Ekso Bionics we believe together we can change the standard of care by supporting patients hopes of early mobility and independence with exoskeleton technology.
See the EksoGT in action: Request a demo
Promotes early mobility and helps correct posture
Allows real-time adjustments to an exoskeleton during rehabilitation
Enables personalization and customization during rehabilitation sessions
Move as one with a breakthrough in-patient rehabilitation and the next generation of variable assist software that promotes early mobility with training, flexible controls, and a rehabilitation friendly user-interface.
At Ekso Bionics we do not just design early mobility aids but rehabilitation tools that give physicians and physical therapists advanced therapeutic options.
See SmartAssist in action: Request a demo today
Innovative techniques to prepare a patient to walk in an exoskeleton
Fewer restrictions and more control to allow the patient to power themselves when appropriate
Rehabilitation friendly user-interface improvement
FES (Functional Electrical Stimulation) is a therapy method where nerves are stimulated with electrical current to cause muscular contraction. FES can enable muscles to be trained even if some or all voluntary control of them has been lost.
Hasomed’s RehaStim2 FES is now integrated into the EksoGT, giving clinicians the synergistic benefits of earlier mobility and muscle stimulation to provide rehabilitation to a broader spectrum of patients — from pre-ambulatory to almost independent.
|Pulse width||20-500 microseconds|
|Channels||Up to 8 stimulation channels|
|Templates||50 default stimulation templates for arm, leg, & torso|
Hasomed’s RehaStim2 FES integration with EksoGT exoskeleton is now CE Marked and available for routine clinical use in Europe. The first European customer installation for the EksoGT exoskeleton with RehaStim2 FES device is slated for January, 2018 and is currently available for investigational research use in the United States.
Cloud-based technology for physical therapists and physicians to obtain insights in rehabilitation to deliver more personalized care and measurable progress for patients using exoskeletons.
At Ekso Bionics we believe in giving people hope, and helping them reimagine their own functional limitations.
See EksoPulse in action: Request a demo today
Quantifiable utilization metrics characterizing rehabilitation
Wireless synchronization with Vodafone cellular technology
Reliable electronic access to patient data